{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:38:58Z","timestamp":1789587538463,"version":"build-2803163510"},"reference-count":61,"publisher":"Bioscientifica","issue":"3","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Computed tomography (CT; unenhanced, followed by contrast-enhanced examinations) is the cornerstone of imaging of adrenal tumours. Attenuation values of &amp;lt;10 Hounsfield units on an unenhanced CT are practically diagnostic for adenomas. When lesions cannot be characterised adequately with CT, magnetic resonance imaging (MRI) evaluation (with T1- and T2-weighted sequences and chemical shift and fat-suppression refinements) is sought. Functional nuclear medicine imaging is useful for adrenal lesions that are not adequately characterised with CT and MRI. Scintigraphy with [131I]-6-iodomethyl norcholesterol (a labelled cholesterol analogue) can differentiate adrenal cortical adenomas from carcinomas. Phaeochromocytomas appear as areas of abnormal and\/or increased uptake of [123I]- and [131I]-meta-iodobenzylguanidine (a labelled noradrenaline analogue). The specific and useful roles of adrenal imaging include the characterisation of tumours, assessment of true tumour size, differentiation of adenomas from carcinomas and metastases, and differentiation of hyperfunctioning from non-functioning lesions. Adrenal imaging complements and assists the clinical and hormonal evaluation of adrenal tumours.<\/jats:p>","DOI":"10.1677\/erc-07-0045","type":"journal-article","created":{"date-parts":[[2007,10,3]],"date-time":"2007-10-03T19:03:02Z","timestamp":1191438182000},"page":"587-599","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":211,"title":["The optimal imaging of adrenal tumours: a comparison of different methods"],"prefix":"10.1530","volume":"14","author":[{"given":"Ioannis","family":"Ilias","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Elena Venizelou Hospital, Athens GR-11521, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Sahdev","sequence":"additional","affiliation":[{"name":"1Departments of Radiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney H","family":"Reznek","sequence":"additional","affiliation":[{"name":"1Departments of Radiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley B","family":"Grossman","sequence":"additional","affiliation":[{"name":"2Endocrinology, St Bartholomew\u2019s Hospital, West Smithfield, London EC1A 7BE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[{"name":"3Section on Medical Neuroendocrinology, Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development, National Institutes of Health, Building 10, CRC, 1 East, Room 1-3140, 10 Center Drive, MSC-1109, Bethesda, Maryland 20892-1109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2026070906065893500_AL-HAWARY-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Al-Hawary\n            MM\n          , Francis IR & Korobkin M 2005 Non-invasive evaluation of the incidentally detected indeterminate adrenal mass. Tumour Biology19277\u2013292.","DOI":"10.1016\/j.beem.2004.09.002"},{"key":"2026070906065893500_BECHERER-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Becherer\n            A\n          , Vierhapper H, Potzi C, Karanikas G, Kurtaran A, Schmaljohann J, Staudenherz A, Dudczak R & Kletter K 2001 FDG-PET in adrenocortical carcinoma. Cancer Biotherapy and Radiopharmaceuticals16289\u2013295.","DOI":"10.1089\/108497801753131363"},{"key":"2026070906065893500_BERTHERAT-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Bertherat\n            J\n          , Mosnier-Pudar H & Bertagna X 2002 Adrenal incidentalomas. Current Opinion in Oncology1458\u201363.","DOI":"10.1097\/00001622-200201000-00011"},{"key":"2026070906065893500_BRAVO-AND-TAGLE-2003","doi-asserted-by":"crossref","unstructured":"Bravo\n            EL\n           & Tagle R 2003 Pheochromocytoma: state-of-the-art and future prospects. Endocrine Reviews24539\u2013553.","DOI":"10.1210\/er.2002-0013"},{"key":"2026070906065893500_CAOILI-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Caoili\n            EM\n          , Korobkin M, Francis IR, Cohan RH, Platt JF, Dunnick NR & Raghupathi KI 2002 Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology222629\u2013633.","DOI":"10.1148\/radiol.2223010766"},{"key":"2026070906065893500_COURCOUTSAKIS-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Courcoutsakis\n            NA\n          , Patronas NJ, Cassarino D, Griffin K, Keil M, Ross JL, Carney JA & Stratakis CA 2004 Hypodense nodularity on computed tomography: novel imaging and pathology of micronodular adrenocortical hyperplasia associated with myelolipomatous changes. Journal of Clinical Endocrinology and Metabolism893737\u20133738.","DOI":"10.1210\/jc.2004-0055"},{"key":"2026070906065893500_DUNNICK-AND-KOROBKIN-2002","doi-asserted-by":"crossref","unstructured":"Dunnick\n            NR\n           & Korobkin M 2002 Imaging of adrenal incidentalomas: current status. American Journal of Roentgenology179559\u2013568.","DOI":"10.2214\/ajr.179.3.1790559"},{"key":"2026070906065893500_ELSAYES-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Elsayes\n            KM\n          , Mukundan G, Narra VR, Lewis JS, Shirkhoda A, Farooki A & Brown JJ 2004 Adrenal masses: MR imaging features with pathologic correlation. Radiographics24S73\u2013S86.","DOI":"10.1148\/rg.24si045514"},{"key":"2026070906065893500_ERIKSSON-ETAL-2005","unstructured":"Eriksson\n            B\n          , Orlefors H, Oberg K, Sundin A, Bergstrom M & Langstrom B 2005 Developments in PET for the detection of endocrine tumours. Tumour Biology19311\u2013324."},{"key":"2026070906065893500_FAJARDO-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Fajardo\n            R\n          , Montalvo J, Velazquez D, Arch J, Bezaury P, Gamino R & Herrera MF 2004 Correlation between radiologic and pathologic dimensions of adrenal masses. World Journal of Surgery28494\u2013497.","DOI":"10.1007\/s00268-004-7292-9"},{"key":"2026070906065893500_FUJITA-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Fujita\n            A\n          , Hyodoh H, Kawamura Y, Kanegae K, Furuse M & Kanazawa K 2000 Use of fusion images of I-131 metaiodobenzylguanidine, SPECT and magnetic resonance studies to identify a malignant pheochromocytoma. Clinical Nuclear Medicine25440\u2013442.","DOI":"10.1097\/00003072-200006000-00010"},{"key":"2026070906065893500_GROSS-ETAL-2007","unstructured":"Gross\n            MD\n          , Avram A, Fig LM & Rubello D 2007 Contemporary adrenal scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging34547\u2013557."},{"key":"2026070906065893500_GRUMBACH-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Grumbach\n            MM\n          , Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC et al.2003 Management of the clinically in apparent adrenal mass (\u2018incidentaloma\u2019). Annals of Internal Medicine138424\u2013429.","DOI":"10.7326\/0003-4819-138-5-200303040-00013"},{"key":"2026070906065893500_HAMRAHIAN-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Hamrahian\n            AH\n          , Ioachimescu AG, Remer EM, Motta-Ramirez G, Bogabathina H, Levin HS, Reddy S, Gill IS, Siperstein A & Bravo EL 2005 Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas\/ hyperplasias from nonadenomas: cleveland clinic experience. Journal of Clinical Endocrinology and Metabolism90871\u2013877.","DOI":"10.1210\/jc.2004-1627"},{"key":"2026070906065893500_VAN-DER-HARST-ETAL-2001","doi-asserted-by":"crossref","unstructured":"van der Harst\n            E\n          , de Herder WW, Bruining HA, Bonjer HJ, de Krijger RR, Lamberts SW, van de Meiracker AH, Boomsma F, Stijnen T, Krenning EP et al.2001 [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas. Journal of Clinical Endocrinology and Metabolism86685\u2013693.","DOI":"10.1210\/jcem.86.2.7238"},{"key":"2026070906065893500_HEINZ-PEER-ETAL-2007","doi-asserted-by":"crossref","unstructured":"Heinz-Peer\n            G\n          , Memarsadeghi M & Niederle B 2007 Imaging of adrenal masses. Current Opinion in Urology1732\u201338.","DOI":"10.1097\/MOU.0b013e328011ea00"},{"key":"2026070906065893500_HOEGERLE-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Hoegerle\n            S\n          , Nitzsche E, Altehoefer C, Ghanem N, Manz T, Brink I, Reincke M, Moser E & Neumann HP 2002 Pheochromocytomas: detection with 18F DOPA whole body PET \u2013 initial results. Radiology222507\u2013512.","DOI":"10.1148\/radiol.2222010622"},{"key":"2026070906065893500_ILIAS-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Ilias\n            I\n          , Yu J, Carrasquillo J, Chen C, Eisenhofer G, Whatley M, McElroy M & Pacak K 2003 Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. Journal of Clinical Endocrinology and Metabolism884083\u20134087.","DOI":"10.1210\/jc.2003-030235"},{"key":"2026070906065893500_ILIAS-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Ilias\n            I\n          , Alesci A & Pacak K 2004 Current views on imaging of adrenal tumours. Hormone and Metabolic Research36430\u2013435.","DOI":"10.1055\/s-2004-814582"},{"key":"2026070906065893500_IMPERIALE-ETAL-2005","unstructured":"Imperiale\n            A\n          , Olianti C, Mannelli M, La Cava G & Pupi A 2005 Tomographic evaluation of [131I] 6beta-iodo-methyl-norcholesterol standardised uptake trend in clinically silent monolateral and bilateral adrenocortical incidentalomas. Quarterly Journal of Nuclear Medicine and Molecular Imaging49287\u2013296."},{"key":"2026070906065893500_ISRAEL-AND-KRINSKY-2003","doi-asserted-by":"crossref","unstructured":"Israel\n            GM\n           & Krinsky GA 2003 MR imaging of the kidneys and adrenal glands. Endocrinology and Metabolism Clinics of North America41145\u2013159.","DOI":"10.1016\/S0033-8389(02)00059-3"},{"key":"2026070906065893500_KOROBKIN-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Korobkin\n            M\n          , Giordano TJ, Brodeur FJ, Francis IR, Siegel-man ES, Quint LE, Dunnick NR, Heiken JP & Wang HH 1996 Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology200743\u2013747.","DOI":"10.1148\/radiology.200.3.8756925"},{"key":"2026070906065893500_KOROBKIN-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Korobkin\n            M\n          , Brodeur FJ, Francis IR, Quint LE, Dunnick NR & Londy F 1998 CT time-attenuation washout curves of adrenal adenomas and nonadenomas. American Journal of Roentgenology170747\u2013752.","DOI":"10.2214\/ajr.170.3.9490968"},{"key":"2026070906065893500_KUMAR-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Kumar\n            R\n          , Xiu Y, Mavi A, El-Haddad G, Zhuang H & Alavi A 2005 FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literature. Clinical Nuclear Medicine30222\u2013230.","DOI":"10.1097\/01.rlu.0000155983.46815.1c"},{"key":"2026070906065893500_LACK-1995","doi-asserted-by":"crossref","unstructured":"Lack\n            EE\n          \n          1995\n          Tumours metastatic to adrenal glands Tumours of the Adrenal Gland and Extra-adrenal Paraganglia. Washington, DC: Armed Forces Institute of Pathology.","DOI":"10.1097\/00000478-199507000-00020"},{"key":"2026070906065893500_LEE-ETAL-2006","unstructured":"Lee\n            CW\n          , Tsang YM & Liu KL 2006 Primary adrenal leiomyosarcoma. Abdominal Imaging31123\u2013124."},{"key":"2026070906065893500_LERTTUMNONGTUM-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Lerttumnongtum\n            P\n          , Muttarak M, Visrutaratna P & YaIn C 2004 Imaging features of unusual adrenal masses. Australasian Radiology48107\u2013113.","DOI":"10.1111\/j.1440-1673.2004.01268.x"},{"key":"2026070906065893500_LI-ETAL-2006","unstructured":"Li\n            Y\n          , Sun H, Gao S & Bai R 2006 Primary bilateral adrenal lymphoma: 2 case reports. Journal of Computer Assisted Tomography30791\u2013793."},{"key":"2026070906065893500_LINGAM-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Lingam\n            RK\n          , Sohaib SA, Rockall AG, Isidori AM, Chew S, Monson JP, Grossman A, Besser GM & Reznek RH 2004 Diagnostic performance of CT versus MR in detecting aldosterone-producing adenoma in primary hyperaldosteronism (Conn\u2019s syndrome). European Radiology141787\u20131792.","DOI":"10.1007\/s00330-004-2308-2"},{"key":"2026070906065893500_LINOS-2000","doi-asserted-by":"crossref","unstructured":"Linos\n            DA\n          \n          2000 Management approaches to adrenal incidentalomas (adrenalomas) a view from Athens, Greece. Endocrinology and Metabolism Clinics of North America29141\u2013157.","DOI":"10.1016\/S0889-8529(05)70121-3"},{"key":"2026070906065893500_LOCKHART-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Lockhart\n            ME\n          , Smith JK & Kenney PJ 2002 Imaging of adrenal masses. European Journal of Radiology4195\u2013112.","DOI":"10.1016\/S0720-048X(01)00444-2"},{"key":"2026070906065893500_MAMEDE-ETAL-2006","doi-asserted-by":"crossref","unstructured":"Mamede\n            M\n          , Carrasquillo JA, Chen CC, Del Corral P, Whatley M, Ilias I, Ayala A & Pacak K 2006 Discordant localization of 2-[18F]-fluoro-2-deoxy-d-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylgua-nidine-negative metastatic pheochromocytoma sites. Nuclear Medicine Communications2731\u201336.","DOI":"10.1097\/01.mnm.0000189780.54658.e8"},{"key":"2026070906065893500_MANN-ETAL-2006","doi-asserted-by":"crossref","unstructured":"Mann\n            GN\n          , Link JM, Pham P, Pickett CA, Byrd DR, Kinahan PE, Krohn KA & Mankoff DA 2006 [(11)C]metahy-droxyephedrine and [(18)f]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma. Annals of Surgical Oncology13187\u2013197.","DOI":"10.1245\/ASO.2006.04.022"},{"key":"2026070906065893500_MANTERO-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Mantero\n            F\n          , Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G & Angeli A 2000 A survey on adrenal incidentaloma in Italy Study Group on Adrenal Tumours of the Italian Society of Endocrinology. Journal of Clinical Endocrinology and Metabolism85637\u2013644.","DOI":"10.1210\/jcem.85.2.6372"},{"key":"2026070906065893500_MAUREA-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Maurea\n            S\n          , Klain M, Caraco C, Ziviello M & Salvatore M 2002 Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours. Nuclear Medicine Communications23951\u2013960.","DOI":"10.1097\/00006231-200210000-00004"},{"key":"2026070906065893500_MAUREA-ETAL-2004","unstructured":"Maurea\n            S\n          , Caraco C, Klain M, Mainolfi C & Salvatore M 2004 Imaging characterization of non-hypersecreting adrenal masses comparison between MR and radionuclide techniques. Quarterly Journal of Nuclear Medicine and Molecular Imaging48188\u2013197."},{"key":"2026070906065893500_MAYO-SMITH-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Mayo-Smith\n            WW\n          , Boland GW, Noto RB & Lee MJ 2001 State-of-the-art adrenal imaging. Radiographics21995\u20131012.","DOI":"10.1148\/radiographics.21.4.g01jl21995"},{"key":"2026070906065893500_OGILVIE-ETAL-2006","unstructured":"Ogilvie\n            CM\n          , Payne S, Evanson J, Lister TA & Grossman AB 2006 Lymphoma metastasizing to the pituitary: an unusual presentation of a treatable disease. Pituitary8139\u2013146."},{"key":"2026070906065893500_PACAK-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Pacak\n            K\n          , Eisenhofer G, Carrasquillo JA, Chen CC, Li ST & Goldstein DS 2001 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension386\u20138.","DOI":"10.1161\/01.HYP.38.1.6"},{"key":"2026070906065893500_PASQUAL-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Pasqual\n            E\n          , Bertolissi F, Grimaldi F, Beltrami CA, Scott CA, Bacchetti S, Waclaw BU & Cagol PP 2002 Adrenal angiosarcoma: report of a case. Surgery Today32563\u2013565.","DOI":"10.1007\/s005950200099"},{"key":"2026070906065893500_RAJARATNAM-AND-WAUGH-2005","doi-asserted-by":"crossref","unstructured":"Rajaratnam\n            A\n           & Waugh J 2005 Adrenal metastases of malignant melanoma: characteristic computed tomography appearances. Australasian Radiology49325\u2013329.","DOI":"10.1111\/j.1440-1673.2005.01440.x"},{"key":"2026070906065893500_RHA-ETAL-2003","unstructured":"Rha\n            SE\n          , Byun JY, Jung SE, Chun HJ, Lee HG & Lee JM 2003 Neurogenic tumours in the abdomen: tumour types and imaging characteristics. Radiographics2329\u201343."},{"key":"2026070906065893500_ROCKALL-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Rockall\n            AG\n          , Babar SA, Sohaib SA, Isidori AM, Diaz-Cano S, Monson JP, Grossman AB & Reznek RH 2004 CT and MR imaging of the adrenal glands in ACTH-independent Cushing syndrome. Radiographics24435\u2013452.","DOI":"10.1148\/rg.242035092"},{"key":"2026070906065893500_ROSSI-2007","doi-asserted-by":"crossref","unstructured":"Rossi\n            GP\n          \n          2007 New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism. Current Hypertension Reports990\u201397.","DOI":"10.1007\/s11906-007-0017-3"},{"key":"2026070906065893500_RUFFINI-ETAL-1992","unstructured":"Ruffini\n            V\n          , Saletnich I & Troncone L 1992 Radiocholesterol scintigraphy in Cushing\u2019s syndrome. Rays1740\u201348."},{"key":"2026070906065893500_SAHDEV-AND-REZNEK-2004","doi-asserted-by":"crossref","unstructured":"Sahdev\n            A\n           & Reznek RH 2004 Imaging evaluation of the nonfunctioning indeterminate adrenal mass. Trends in Endocrinology and Metabolism15271\u2013276.","DOI":"10.1016\/j.tem.2004.06.012"},{"key":"2026070906065893500_SCHULZ-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Schulz\n            C\n          , Eisenhofer G & Lehnert H 2004 Principles of Catecholamine Biosynthesis, Metabolism and Release. Frontiers of Hormone Research311\u20132.","DOI":"10.1159\/000074656"},{"key":"2026070906065893500_SHULKIN-ETAL-1995","unstructured":"Shulkin\n            BL\n          , Wienland DM, Shapiro B & Sisson JC 1995 PET epinephrine studies of pheochromocytoma. Journal of Nuclear Medicine36229P."},{"key":"2026070906065893500_SHULKIN-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Shulkin\n            BL\n          , Thompson NW, Shapiro B, Francis IR & Sisson JC 1999 Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy- d-glucose PET. Radiology21235\u201341.","DOI":"10.1148\/radiology.212.1.r99jl3035"},{"key":"2026070906065893500_SLATTERY-ETAL-2006","doi-asserted-by":"crossref","unstructured":"Slattery\n            JM\n          , Blake MA, Kalra MK, Misdraji J, Sweeney AT, Copeland PM, Mueller PR & Boland GW 2006 Adrenocortical carcinoma: contrast washout characteristics on CT. American Journal of Roentgenology187W21\u2013W24.","DOI":"10.2214\/AJR.04.1751"},{"key":"2026070906065893500_SOHAIB-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Sohaib\n            SA\n          , Hanson JA, Newell-Price JD, Trainer PJ, Monson JP, Grossman AB, Besser GM & Reznek RH 1999 CT Appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing\u2019s syndrome. American Journal of Roentgenology172997\u20131002.","DOI":"10.2214\/ajr.172.4.10587135"},{"key":"2026070906065893500_SOHAIB-ETAL-2001","unstructured":"Sohaib\n            SAA\n          , Bomanji J, Evanson J & Reznek RH 2001 Imaging of the endocrine system. Grainger & Allison\u2019s Diagnostic Radiology \u2013 A Textbook of Medical Imaging, pp 1367\u20131399. Eds RG Grainger, DJ Allison, A Adam & AK Dixon., 5 London: Churchill Livingstone."},{"key":"2026070906065893500_SZOLAR-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Szolar\n            DH\n          , Korobkin M, Reittner P, Berghold A, Bauernhofer T, Trummer H, Schoellnast H, Preidler KW & Samonigg H 2005 Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology234479\u2013485.","DOI":"10.1148\/radiol.2342031876"},{"key":"2026070906065893500_TENENBAUM-ETAL-1995","unstructured":"Tenenbaum\n            F\n          , Lumbroso J, Schlumberger M, Mure A, Plouin PF, Caillou B & Parmentier C 1995 Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. Journal of Nuclear Medicine361\u20136."},{"key":"2026070906065893500_TENENBAUM-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Tenenbaum\n            F\n          , Groussin L, Foehrenbach H, Tissier F, Gouya H, Bertherat J, Dousset B, Legmann P, Richard B & Bertagna X 2004 18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients European Journal of Endocrinology150789\u2013792.","DOI":"10.1530\/eje.0.1500789"},{"key":"2026070906065893500_THOMPSON-AND-YOUNG-2003","unstructured":"Thompson\n            GB\n           & Young WF Jr 2003 Adrenal incidentaloma. Current Opinion in Oncology1584\u201390."},{"key":"2026070906065893500_TROJAN-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Trojan\n            J\n          , Schwarz W, Sarrazin C, Thalhammer A, Vogl TJ & Dietrich CF 2002 Role of ultrasonography in the detection of small adrenal masses. Ultraschall in der Medizin2396\u2013100.","DOI":"10.1055\/s-2002-25190"},{"key":"2026070906065893500_UEBERBERG-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Ueberberg\n            B\n          , Tourne H, Redman A, Walz MK, Schmid KW, Mann K & Petersenn S 2005 Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumours and normal adrenal gland. Hormone and Metabolic Research37722\u2013728.","DOI":"10.1055\/s-2005-921092"},{"key":"2026070906065893500_VINCENT-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Vincent\n            JM\n          , Morrison ID, Armstrong P & Reznek RH 1994 The size of normal adrenal glands on computed tomography. Clinical Radiology49453\u2013455 (Erratum Clin Radiol Vol. 50 (1995) 202).","DOI":"10.1016\/S0009-9260(05)83070-3"},{"key":"2026070906065893500_YOUNG-2003","unstructured":"Young\n            WF\n           Jr 2003 Primary aldosteronism\u2013changing concepts in diagnosis and treatment. Endocrinology1442208\u20132213."},{"key":"2026070906065893500_YOUNG-2007","unstructured":"Young\n            WF\n           Jr 2007 The incidentally discovered adrenal mass. New England Journal of Medicine356601\u2013610."}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/14\/3\/0140587.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/14\/3\/587\/151258\/0140587.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/14\/3\/587\/151258\/0140587.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:07:16Z","timestamp":1783591636000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/14\/3\/587\/26905\/The-optimal-imaging-of-adrenal-tumours-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9,1]]}},"URL":"https:\/\/doi.org\/10.1677\/erc-07-0045","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9,1]]}}}